September 14, 2016—More than 300 older generic drugs covered by Medicare Part D had one or more “extraordinary” price increases of 100 percent or more between 2010 and 2015, a government watchdog agency says in a new report.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)